Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, announced today that Ewan Phillips has resigned as Chief Executive and as a Director of the Company with immediate effect.
Mr. Phillips recently approached Deltex’s Chairman indicating that he had concluded that it was now time for a change in leadership to guide the Group through its next stage of development. After leading the Group for a number of years, he felt that Deltex was now well-positioned following the successful fund raising in February 2018, recent cost reductions, the launch of the TrueVue platform, the recently published FEDORA study and repositioning of both its core clinical and health economic propositions.
Andy Mears, who is currently the Managing Director of Deltex Medical Limited, the Group’s principal operating subsidiary, has been appointed as the Group’s new Chief Executive and a Director of the Company. The Board appointment is subject to completion of certain regulatory formalities.
Mr. Mears, aged 49, started at Deltex Medical Group plc as an engineer in 1989 and has worked in a number of operational roles in the Group. Within his current role, he has responsibility for international sales and Deltex’s Key Opinion Leader development programmes.
